Clinical Trials Logo

Clinical Trial Summary

Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06384703
Study type Observational
Source Konya Beyhekim Training and Research Hospital
Contact
Status Completed
Phase
Start date November 3, 2020
Completion date June 18, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05592327 - Citric Acid Passivation on Implant Abutments for the Prevention of Peri-implant Disease N/A
Active, not recruiting NCT05108675 - Microbiome and Malnutrition in Pregnancy (MMiP)
Active, not recruiting NCT04781036 - Foot-skin Microbiome and Metabolomics of Pitted Keratolysis N/A
Recruiting NCT03962920 - Personalized Treatment of Urogenital Cancers Depends on the Microbiome N/A
Recruiting NCT05763680 - Molecular Culture for the Diagnosis of Neonatal Sepsis
Completed NCT04542759 - Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery Phase 1
Recruiting NCT05759741 - Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy Early Phase 1
Recruiting NCT04992104 - Microbiome and Malnutrition in Pregnancy
Recruiting NCT06274931 - Analysis of the Pulmonary Microbiome
Completed NCT03225950 - Interaction Between Immune Cells and Bacteria Associated With Periodontitis